Literature DB >> 20236864

Primary immunodeficiencies of protective immunity to primary infections.

Aziz Bousfiha1, Capucine Picard, Stéphanie Boisson-Dupuis, Shen-Ying Zhang, Jacinta Bustamante, Anne Puel, Emmanuelle Jouanguy, Fatima Ailal, Jamila El-Baghdadi, Laurent Abel, Jean-Laurent Casanova.   

Abstract

The vast majority of primary immunodeficiencies (PIDs) predispose affected individuals to recurrent or chronic infectious diseases, because they affect protective immunity to both primary and secondary or latent infections. We discuss here three recently described groups of PIDs that seem to impair immunity to primary infections without compromising immunity to secondary and latent infections. Patients with mutations in IL12B or IL12RB1 typically present mycobacterial disease in childhood with a favorable progression thereafter. Cross-protection between mycobacterial infections has even been observed. Patients with mutations in IRAK4 or MYD88 suffer from pyogenic bacterial diseases, including invasive pneumococcal diseases in particular. These diseases often recur, although not always with the same serotype, but the frequency of these recurrences tails off, with no further infections observed from adolescence onwards. Finally, mutations in UNC93B1 and TLR3 are associated with childhood herpes simplex encephalitis, which strikes only once in most patients, with almost no recorded cases of more than two bouts of this disease. Unlike infections in patients with other PIDs, the clinical course of which typically deteriorates with age even if appropriate treatment is given, the prognosis of patients with these three newly described PIDs tends to improve spontaneously with age, provided, of course, that the initial infection is properly managed. In other words, although life-threatening in early childhood, these new PIDs are associated with a favorable outcome in adulthood. They provide proof-of-principle that infectious diseases of childhood striking only once may result from single-gene inborn errors of immunity. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20236864     DOI: 10.1016/j.clim.2010.02.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  20 in total

1.  Beyond pattern recognition: five immune checkpoints for scaling the microbial threat.

Authors:  J Magarian Blander; Leif E Sander
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

Review 2.  Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

Authors:  S Gruenheid; P Gros
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

Review 3.  Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.

Authors:  Man Yu; Stewart J Levine
Journal:  Cytokine Growth Factor Rev       Date:  2011-04-03       Impact factor: 7.638

Review 4.  True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity.

Authors:  Edward S Mocarski; William J Kaiser; Devon Livingston-Rosanoff; Jason W Upton; Lisa P Daley-Bauer
Journal:  J Immunol       Date:  2014-03-01       Impact factor: 5.422

Review 5.  Manipulation of apoptosis and necroptosis signaling by herpesviruses.

Authors:  Hongyan Guo; William J Kaiser; Edward S Mocarski
Journal:  Med Microbiol Immunol       Date:  2015-04-01       Impact factor: 3.402

Review 6.  Genetic variation in Toll-like receptors and disease susceptibility.

Authors:  Mihai G Netea; Cisca Wijmenga; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2012-05-18       Impact factor: 25.606

7.  Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection.

Authors:  Susanne E Kampmann; Birgit Schindele; Luise Apelt; Christoph Bührer; Lars Garten; Katharina Weizsaecker; Detlev H Krüger; Bernhard Ehlers; Jörg Hofmann
Journal:  Med Microbiol Immunol       Date:  2010-12-17       Impact factor: 3.402

8.  Bacille Calmette-Guérin lymphadenitis and recurrent oral candidiasis in an infant with a new mutation leading to interleukin-12 receptor beta-1 deficiency.

Authors:  C Aytekin; F Dogu; N Tuygun; G Tanir; D Guloglu; S Boisson-Dupuis; J Bustamante; J Feinberg; J L Casanova; A Ikinciogullari
Journal:  J Investig Allergol Clin Immunol       Date:  2011       Impact factor: 4.333

9.  Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.

Authors:  Laura Sticchi; Bianca Bruzzone; Patrizia Caligiuri; Emanuela Rappazzo; Michele Lo Casto; Laura De Hoffer; Giulia Gustinetti; Claudio Viscoli; Antonio Di Biagio
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

10.  Primary immunodeficiency diseases worldwide: more common than generally thought.

Authors:  Ahmed Aziz Bousfiha; Leïla Jeddane; Fatima Ailal; Ibtihal Benhsaien; Nizar Mahlaoui; Jean-Laurent Casanova; Laurent Abel
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.